当前位置:
X-MOL 学术
›
Mediterr. J. Hematol. Infect. Dis.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Venetoclax-Rituximab Treatment of Relapsed/Refractory CLL During the COVID-19 Pandemic: A Real-Life Experience in Selected Central-Southern Italian Regions.
Mediterranean Journal of Hematology and Infectious Diseases ( IF 2.0 ) Pub Date : 2021-07-01 , DOI: 10.4084/mjhid.2021.042 Stefano Molica 1 , Paolo Sportoletti 2 , Nicola Di Renzo 3 , Pellegrino Musto 4 , Fabrizio Pane 5 , Francesco Di Raimondo 6
中文翻译:
在 COVID-19 大流行期间 Venetoclax-Rituximab 治疗复发/难治性 CLL:意大利中南部特定地区的真实生活体验。
更新日期:2021-07-01
Mediterranean Journal of Hematology and Infectious Diseases ( IF 2.0 ) Pub Date : 2021-07-01 , DOI: 10.4084/mjhid.2021.042 Stefano Molica 1 , Paolo Sportoletti 2 , Nicola Di Renzo 3 , Pellegrino Musto 4 , Fabrizio Pane 5 , Francesco Di Raimondo 6
Affiliation
中文翻译:
在 COVID-19 大流行期间 Venetoclax-Rituximab 治疗复发/难治性 CLL:意大利中南部特定地区的真实生活体验。